Dyno Therapeutics operates at the intersection of artificial intelligence and molecular biology, focusing on the development of high-performance gene delivery technologies. The company's central work involves AI-powered capsid engineering, a specialised approach to improving the vehicles used to deliver genetic medicines to target cells.
The company's work spans several technical domains, including artificial intelligence, molecular biology, and gene therapy. Its primary industry verticals are genetic medicine, biotechnology, and pharmaceuticals, positioning it within a rapidly advancing area of therapeutic development.
Dyno Therapeutics describes its culture as one grounded in intellectual rigour and scientific curiosity. The company states that it seeks bold thinkers who embrace the scientific process, are not afraid to pursue ambitious goals, and possess the courage to speak hard truths. Team members, referred to internally as "AAViators," are said to be empowered to contribute meaningfully as priorities evolve, with a relentless pursuit of excellence cited as a core value.
